During the past decade, KLB Gesundheitsforschung Lübeck GmbH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "KLB Gesundheitsforschung Lübeck GmbH" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "KLB Gesundheitsforschung Lübeck GmbH" are "Pulmonary Disease, Chronic Obstructive" (4 trials), "Asthma" (2 trials), "Bronchiectasis" (1 trials), "Chronic Bronchitis" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "KLB Gesundheitsforschung Lübeck GmbH" in a lesser frequency.

Most popular intervention types in "KLB Gesundheitsforschung Lübeck GmbH" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "BI 1026706" (1 trials), "BI 1291583" (1 trials), "BI 1323495" (1 trials) and "Fluticasone propionate" (1 trials). Other intervention names were less common.

The vast majority of trials in "KLB Gesundheitsforschung Lübeck GmbH" are 9 trials for "All" genders.

Currently, there are NaN active trials in "KLB Gesundheitsforschung Lübeck GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in KLB Gesundheitsforschung Lübeck GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in KLB Gesundheitsforschung Lübeck GmbH, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".